AKEBIA THERAPEUTICS INC's ticker is AKBA and the CUSIP is 00972D105. A total of 166 filers reported holding AKEBIA THERAPEUTICS INC in Q3 2020. The put-call ratio across all filers is 1.12 and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2022 | $17,000 | -85.6% | 24,241 | -53.5% | 0.00% | – |
| Q4 2021 | $118,000 | +63.9% | 52,146 | +108.3% | 0.00% | -100.0% |
| Q3 2021 | $72,000 | -26.5% | 25,033 | -2.8% | 0.00% | 0.0% |
| Q2 2021 | $98,000 | +28.9% | 25,765 | +15.1% | 0.00% | -66.7% |
| Q1 2021 | $76,000 | +20.6% | 22,384 | 0.0% | 0.00% | +50.0% |
| Q4 2020 | $63,000 | +12.5% | 22,384 | +0.5% | 0.00% | 0.0% |
| Q3 2020 | $56,000 | -80.2% | 22,266 | +6.9% | 0.00% | -84.6% |
| Q2 2020 | $283,000 | +102.1% | 20,820 | +13.0% | 0.01% | +333.3% |
| Q1 2020 | $140,000 | +15.7% | 18,426 | -4.1% | 0.00% | +50.0% |
| Q4 2019 | $121,000 | +75.4% | 19,206 | +9.7% | 0.00% | +100.0% |
| Q3 2019 | $69,000 | -19.8% | 17,503 | -1.2% | 0.00% | -50.0% |
| Q2 2019 | $86,000 | -21.8% | 17,713 | +32.4% | 0.00% | -33.3% |
| Q1 2019 | $110,000 | +52.8% | 13,377 | +3.4% | 0.00% | +50.0% |
| Q4 2018 | $72,000 | – | 12,939 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Alerce Investment Management, L.P. | 4,652,561 | $3,340,000 | 5.66% |
| Orchard Capital Management, LLC | 1,762,731 | $1,265,000 | 0.36% |
| Ikarian Capital, LLC | 1,200,000 | $860,000 | 0.11% |
| Ikarian Capital, LLC | 800,000 | $575,000 | 0.08% |
| XTX Topco Ltd | 102,392 | $74,000 | 0.03% |
| Nantahala Capital Management | 965,800 | $693,000 | 0.03% |
| Worth Venture Partners, LLC | 63,500 | $46,000 | 0.02% |
| Ardent Capital Management, Inc. | 43,429 | $31,000 | 0.02% |
| Virtus ETF Advisers LLC | 65,149 | $47,000 | 0.02% |
| RICE HALL JAMES & ASSOCIATES, LLC | 513,292 | $368,000 | 0.02% |